Potential Non-Invasive Biomarkers in Cancer and Sepsis
To view this email as a web page, go here.

Profiling of Soluble Immune Checkpoint Proteins as Potential Non-Invasive Biomarkers in Colorectal Cancer and Sepsis

In recent years, targeting immune checkpoint proteins has been shown to be an innovation for treatment of cancer and immune-related adverse events. Many checkpoint molecules have been identified on immune cells and/or tumor cells as activating receptors or inhibitory receptors. Many immune checkpoint proteins are also expressed as soluble forms in circulation, easily accessible as potential biomarker candidates.

This report covers the development of a bead-based multiplex assay for the quantitative profiling of a panel of co-inhibitory and co-stimulating immune checkpoint proteins. 

Learn More
SUBSCRIBE | ABOUT US | ADVERTISE
We respect your right to privacy - view our policy here.
This mailbox is unattended, so please do not reply to this message. Contact us for assistance.
If you no longer wish to receive these emails - unsubscribe here.
This email was sent by: Bioscience Technology
100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129
© 2018 Bioscience Technology. All rights reserved.